The peptide synthesis market is projected to grow at a CAGR of 6.5%

LONDON, July 23, 2018 /PRNewswire/ -- The peptide synthesis market is projected to grow at a CAGR of 6.5% in the next five yearsDownload the full report: https://www.reportbuyer.com/product/5477768 The peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5% during the forecast period. Factors such as increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced peptide synthesizers are expected to drive the growth of the market. However, the lack of a unified set of regulations for therapeutic peptides is expected to restrain the growth of this market during the forecast period.The solid-phase synthesis segment accounted for the largest market share and is expected to grow at the highest CAGR during the forecast periodBy technology, the peptide synthesis market is segmented into solid-phase, liquid -phase, and hybrid & recombinant technology.Solid-phase synthesis is associated with a number of advantages, such as ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids.Such advantages are expected to drive the adoption of solid-phase synthesis.The contract development and manufacturing organizations segment is projected to grow at the highest CAGR during the forecast periodBy end user, the market is segmented into pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and academic and research institutes.The contract development and manufacturing organizations segment is expected to grow at the highest CAGR during the forecast period.The increasing demand for cost-effective peptide synthesis services in drug development activities and life science research is driving the growth of this segment.North America is projected to have the largest market share during the forecast period (2018-2023)North America dominated the peptide synthesis market in 2017, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa.North America accounted for the largest share of the peptide synthesis market.The large share of North America in this market can be attributed to the high prevalence of chronic diseases, increasing investments in the development of structure-based drug designs, and growing research in the fields of genomics and proteomics in the region.Break of primary participants was as mentioned below:• By Company Type – Tier 1–45%, Tier 2–40% and Tier 3–15%• By Designation – C-level–41%, Director Level–30%, Others–29%• By Region – North America–32%, Europe–27%, Asia-Pacific–19%, Latin America–12%, Middle East & Africa- 10%The major players in the peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGAA (Germany) and New England Peptide (US).Research Coverage:The peptide synthesis market in this report is segmented by product, technology, end user, and regions.It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges).The study tracks and analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions, new product developments, geographical expansions, and R&D activities) and strategically profiles the key players and comprehensively analyzes their market shares and core competencies in the peptide synthesis market.Reasons to buy this report:From an insight perspective, this research report has focused on various levels of analysis—market share analysis of top players, company profiles which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the peptide synthesis market; high-growth regions; and market drivers, restraints, and opportunities. The report provides the latest peptide synthesis industry statistics and industry trends, allowing buyers to identify the high growth product segment and potential customers and suppliers hence driving revenue growth and profitability.The report provides insights on the following pointers:• Market Penetration: Comprehensive information on products offered by the top players in the global peptide synthesis market• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the peptide synthesis market• Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for peptide synthesis market across regions• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global peptide synthesis market• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global peptide synthesis marketDownload the full report: https://www.reportbuyer.com/product/5477768 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Advertisement

View original content:http://www.prnewswire.com/news-releases/the-peptide-synthesis-market-is-projected-to-grow-at-a-cagr-of-6-5-300684776.html

SOURCE ReportBuyer